Background The aim of this study was to analyze the clinical and metabolic changes
| INTRODUCTION
Type 1 diabetes is a known risk factor for adverse pregnancy outcomes.
Since the St Vincent Declaration of 1989, 1 which was aimed to achieve similar pregnancy outcomes in women with and without diabetes, tight glycemic control has been introduced into all the current guidelines. However, recent cohort studies still show a 3-to 5-fold greater risk of adverse perinatal and obstetric outcomes in women with type 1 diabetes than in the general population, albeit with an improvement in glycemic control. [2] [3] [4] It is therefore recommended that all women of childbearing age with type 1 diabetes plan pregnancy on order to achieve optimal glycemic control, evaluate diabetes-related complications, and refresh their knowledge and skills about diabetes. [5] [6] [7] [8] Different regional programs have demonstrated that prepregnancy care (PPC) is associated with an 80% reduction of serious adverse pregnancy outcomes (major congenital malformation, stillbirth, or neonatal death) and lower rates of very premature delivery. [9] [10] [11] [12] However, despite the known benefits of
| Data collection
In the baseline visit, we collected demographic data, smoking status, history of prior obstetric outcomes, physical examination (including detection of lipodystrophy), and the presence of other comorbidities, such as hypertension (defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or taking antihypertensive drugs), dyslipidemia (defined as taking lipid-lowering drugs), and thyroid disease. Weight, body mass index (BMI), and blood pressure were obtained by standardized methods every visit until the end of the follow-up. Microvascular complications were screened at the first visit by digital retinal photography in women with no history of retinopathy, the first urine sample collection (microalbuminuria), and evaluation of symptoms of neuropathy. The presence of macrovascular complication was defined as a history of ischemic heart disease or stroke. In cases of lengthy PPC, screening for diabetes-related complications was repeated according to guidelines. The SH events were collected on subsequent visits.
| Pregnancy outcomes
The pregnancy outcomes evaluated were primary cesarean delivery, gestational hypertensive disease (including gestational hypertension and preeclampsia), large for gestational age as birth weight above the 90th centile for gestational age, small for gestational age defined as birth weight below the 3rd centile for gestational age, macrosomia defined as neonatal weight at or above 4000 g, prematurity (delivery before 37.0 wk), severe prematurity (delivery before 34.0 wk), and neonatal hypoglycemia defined as plasma glucose levels of <2.5 mmol/L in the first 24 hours of life and <2.8 mmol/L thereafter.
Gestational age was defined as completed weeks based on last menstrual period or the earliest ultrasound assessment if discordant.
| Diabetes-related questionnaires
On the first visit, we evaluated diabetes self-management education and quality of life using 3 different questionnaires:
• Diabetes Knowledge Questionnaire (DKQ2) test to evaluate diabetes knowledge (maximum score of 35).
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| RESULTS
During the study period, 104 women with type 1 diabetes attended the PPC program. Forty-nine patients (47.1%) had had a previous gestation (median 1 pregnancy [IQI 1-2]), and 75.0% had previously attended PPC. Table 1 shows the baseline characteristics of the patients included. Taking into account not only the baseline characteristics but also variables related to PPC, HbA 1c at the end of PPC remained independently associated with baseline HbA 1c (β = .318, P = .001) and number of previous pregnancies (β = .224, P = .038), even after adjustment for age, diabetes duration, program duration, increased incidence of SH, The PPC was accompanied by weight gain (1.4 ± 4.0 kg, P = .003) without a significant change in insulin requirements (+0.01 ± 0.13/kg/ day, P = .595). Weight gain was independently associated with a greater decrease in HbA 1c (β = .222, P = .047) and longer duration in the PPC program (β = .337, P = .002) after adjustment for age, baseline BMI, increase of insulin dose, episodes of SH, and dropout.
| Metabolic changes during PPC
Ten patients started insulin pump therapy, 9 for not achieving optimal glycemic control and 1 for repeated SH (32.7% patients with insulin pump therapy in the first visit vs 42.3% in the last visit, P = .002). No episode of diabetic ketoacidosis was presented during the PPC program.
| Hypoglycemia
At baseline, women presented a mean of 4.5 ± 3. 
| Dropouts
Thirty-three patients (31.7%) dropped out from the program because of infertility (n = 12; 36.4%), family problems (n = 12; 36.4%), unexplained cessation of the follow-up (n = 6; 18.2%), failure to Abbreviations: BMI, body mass index; SMBG, self-monitoring of blood glucose per day; SH, severe hypoglycemia; SCI-R, Diabetes Self-Care InventoryRevised Version.
Data are expressed as mean ± standard deviation in normal distribution or median [interquartile interval] in non-normal distribution.
SCI-R questionnaire: evaluate adherence to diabetes self-care recommendations over the previous 1-2 months (high scores indicate maximum adherence).
Statistically significant differences in bold. a Includes data from 61 patients.
b Includes data from 53 patients.
achieve glycemic target (n = 1; 3%), and a concomitant illness (n = 2;
6.1%). The median duration of PPC was longer in the dropout group because of the longer time from the recommendation for pregnancy to the end of follow-up (dropout: median 15.9 mo [IQI 7.6-20.4] vs non-dropout: median 3.5 mo [IQI 0.9-13.9]; P < .001). Dropouts were older (P = .017), more overweight (P = .023) and had a higher final HbA 1c (P = .006) compared with non-dropouts, with no other differences ( Table 2 ). Age (OR 1.17, 95% CI 1.04-1.36) and PPC duration (OR 1.06, 95% CI 1.02-1.11) were independent factors for discontinuing the program after adjustment for confounders (age, duration in PPC, baseline HbA 1c , baseline BMI, diabetes duration, previous pregnancy, and recommendation for pregnancy).
| Pregnancies outcomes
Of the total cohort in PPC, 71 women became pregnant. Twenty-one pregnancies (29.6% of total pregnancies) were without medical professional recommendation for pregnancy and with a mean HbA 1c
7.5 ± 0.7% (58.2 ± 7.3 mmol/mol). Of these women, 28.6% and 58.4%
were not taking folic acid or iodine supplementation, respectively. [24] [25] [26] [27] A population-based study showed that a 10% reduction of prepregnancy BMI was associated with 10% lower risk of preeclampsia, gestational diabetes, preterm delivery, macrosomia, and stillbirth. 28 In our high-risk cohort, PPC was accompanied by a >10% increase in BMI in 8.3% of women and >5% in 1 out of 4, which could have a negative impact on pregnancy outcomes.
Established risk factors for SH in the nonpregnant population, include age, duration of diabetes, tight glycemic control, previous SH, and impaired hypoglycemia awareness. 14 During pregnancy, SH is usually associated with a history of previous SH, diabetes duration, and rapid improvement of glycemic control in the first trimester. 15 On evaluating the risk factors during PPC, we only found that a history of previous SH (11-fold increase) and the length of PPC (9% increase for every PPC month) remained independently associated with SH. These findings suggest that the risk of SH is more related to the time under strict glycemic control than the duration of diabetes itself. We did not find a significant increase in SH events. Our population presented a low risk of SH, with only 0.08 SH per patient-year compared with previous studies reporting higher frequencies. 15, 16, 29 On the other hand, in the last years, an intervention focused on SH in routine care with increased use of insulin analogs and greater use of insulin pumps reported decreased rates of SH. [30] [31] [32] [33] In a high-risk population such as pregnant women, (with tighter glycemic goals) Ringholm et al also showed a reduction of 36% in the incidence of SH between 2 different periods (from 2004-2006 and 2009-2011) with no deterioration in metabolic control. 16 In our study, the low incidence of SH is probably because of the use of insulin analogs FIGURE 1 Predictors of severe hypoglycemia during the prepregnancy care program. Logistic regression model for the probability of presenting severe hypoglycemia during the prepregnancy care program adjusted for dropout from follow-up, decreased HbA 1c , history of severe hypoglycemia (SH), diabetes duration, program duration, and age. Odds ratio and 95% confidence interval reported by most of the women included and the high percentage of insulin pump
